EP1968586A4 - Pharmaceutical compositions and methods for improved bacterial eradication - Google Patents

Pharmaceutical compositions and methods for improved bacterial eradication

Info

Publication number: EP1968586A4
Authority: EP; European Patent Office
Prior art keywords: methods; pharmaceutical compositions; improved bacterial; bacterial eradication; eradication
Prior art date: 2005-12-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06845116A

Other languages

German (de)

French (fr)

Other versions

EP1968586A2 (en

Inventor

Henry H Flanner

Robert J Guttendorf

Susan P Clausen

Donald Treacy

Beth A Burnside

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Shionogi Inc

Original Assignee

Advancis Pharmaceutical Corp

MiddleBrook Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-08

Filing date

2006-12-08

Publication date

2011-12-21

2006-12-08 Application filed by Advancis Pharmaceutical Corp, MiddleBrook Pharmaceuticals Inc filed Critical Advancis Pharmaceutical Corp

2008-09-17 Publication of EP1968586A2 publication Critical patent/EP1968586A2/en

2011-12-21 Publication of EP1968586A4 publication Critical patent/EP1968586A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP06845116A 2005-12-08 2006-12-08 Pharmaceutical compositions and methods for improved bacterial eradication Withdrawn EP1968586A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US74866005P	2005-12-08	2005-12-08
US79810906P	2006-05-05	2006-05-05
PCT/US2006/047040 WO2007067770A2 (en)	2005-12-08	2006-12-08	Pharmaceutical compositions and methods for improved bacterial eradication

Publications (2)

Publication Number	Publication Date
EP1968586A2 EP1968586A2 (en)	2008-09-17
EP1968586A4 true EP1968586A4 (en)	2011-12-21

Family

ID=38123546

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06845116A Withdrawn EP1968586A4 (en)	2005-12-08	2006-12-08	Pharmaceutical compositions and methods for improved bacterial eradication

Country Status (4)

Country	Link
EP (1)	EP1968586A4 (en)
AU (1)	AU2006321782B2 (en)
CA (1)	CA2635378C (en)
WO (1)	WO2007067770A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5672359A (en) *	1993-07-21	1997-09-30	The University Of Kentucky Research Foundation	Multicompartment hard capsule with control release properties
US20010048944A1 (en) *	2000-02-24	2001-12-06	Rudnic Edward M.	Antibiotic product, use and formulation thereof
US20020136766A1 (en) *	2000-02-24	2002-09-26	Rudnic Edward M.	Tetracycline antibiotic product, use and formulation thereof
US20030077323A1 (en) *	2000-02-24	2003-04-24	Rudnic Edward M.	Amoxicillin - clarithromycin antibiotic composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060121106A1 (en) *	2003-02-21	2006-06-08	Janez Kerc	Therapeutic system comprising amoxicillin and clavulanic acid
BR0318535A (en) *	2003-09-30	2006-09-12	Lupin Ltd	pharmaceutical composition for controlled drug delivery, process for preparing a pharmaceutical composition and controlled release composition

2006
- 2006-12-08 EP EP06845116A patent/EP1968586A4/en not_active Withdrawn
- 2006-12-08 AU AU2006321782A patent/AU2006321782B2/en not_active Ceased
- 2006-12-08 CA CA2635378A patent/CA2635378C/en not_active Expired - Fee Related
- 2006-12-08 WO PCT/US2006/047040 patent/WO2007067770A2/en not_active Ceased

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5672359A (en) *	1993-07-21	1997-09-30	The University Of Kentucky Research Foundation	Multicompartment hard capsule with control release properties
US20010048944A1 (en) *	2000-02-24	2001-12-06	Rudnic Edward M.	Antibiotic product, use and formulation thereof
US20020136766A1 (en) *	2000-02-24	2002-09-26	Rudnic Edward M.	Tetracycline antibiotic product, use and formulation thereof
US20030077323A1 (en) *	2000-02-24	2003-04-24	Rudnic Edward M.	Amoxicillin - clarithromycin antibiotic composition

Also Published As

Publication number	Publication date
CA2635378C (en)	2015-06-16
WO2007067770A3 (en)	2008-02-21
WO2007067770A2 (en)	2007-06-14
AU2006321782A1 (en)	2007-06-14
EP1968586A2 (en)	2008-09-17
CA2635378A1 (en)	2007-06-14
AU2006321782B2 (en)	2012-11-29

Publication	Publication Date	Title
PL1962873T3 (en)	2014-03-31	Pharmaceutical compositions comprising oxalate-reducing bacteria
IL190292A (en)	2017-01-31	Pyridopyrimidinone derivatives and pharmaceutical compositions comprising them
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
IL186127A (en)	2015-09-24	Pharmaceutical compositions for treating depression and methods for preparing the same
IL186336A0 (en)	2008-01-20	Pharmaceutical composition
ZA200804851B (en)	2009-07-29	Compositions and methods for cell killing
IL188352A0 (en)	2008-04-13	Pharmaceutical compositions
IL190239A0 (en)	2008-11-03	Pharmaceutical gallium compositions and methods
ZA200804103B (en)	2009-10-28	Pharmaceutical compositions
IL188521A0 (en)	2008-04-13	Compositions and methods for protein deaggregation
IL185197A0 (en)	2008-01-06	Ophthalmological pharmaceutical compositions
EP2025667A4 (en)	2012-08-29	9,10-secopregnane derivative and pharmaceutical
IL192091A0 (en)	2008-12-29	Pharmaceutical compositions
IL186337A0 (en)	2008-01-20	Stannsoporfin compositions and administration
GB0522045D0 (en)	2005-12-07	Pharmaceutical compositions
EP1968586A4 (en)	2011-12-21	Pharmaceutical compositions and methods for improved bacterial eradication
EP1845944A4 (en)	2011-07-27	Pharmaceutical compositions
GB0501348D0 (en)	2005-03-02	Compositions and methods
EP1865777A4 (en)	2008-07-16	Stannsoporfin compositions and administration
GB0514259D0 (en)	2005-08-17	Pharmaceutical compositions
ZA200803566B (en)	2009-10-28	Pharmaceutical compositions
AU2005906601A0 (en)	2005-12-08	Therapeutic methods and compositions
GB0517546D0 (en)	2005-10-05	Therapeutic methods and compositions
HK1104476A (en)	2008-01-18	Pharmaceutical compositions and methods for peptide treatment
GB0518166D0 (en)	2005-10-12	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2008-08-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2008-09-17	17P	Request for examination filed	Effective date: 20080708
2008-09-17	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-09-17	AX	Request for extension of the european patent	Extension state: AL BA HR MK RS
2009-05-06	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.
2011-12-21	A4	Supplementary search report drawn up and despatched	Effective date: 20111117
2011-12-21	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/50 20060101ALI20111111BHEP Ipc: A61K 9/54 20060101ALI20111111BHEP Ipc: A61K 9/52 20060101ALI20111111BHEP Ipc: A61K 9/24 20060101ALI20111111BHEP Ipc: A61K 9/20 20060101ALI20111111BHEP Ipc: A61K 9/14 20060101AFI20111111BHEP
2011-12-28	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SHIONOGI INC.
2012-08-22	17Q	First examination report despatched	Effective date: 20120724
2017-07-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2020-10-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2020-11-25	18D	Application deemed to be withdrawn	Effective date: 20200701